Abiopharma

ROCKET LAB CORP (RKLB) Reports the reporting period Financial Results ROCKET LAB CORP (RKLB) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 123855
• Net Income: $127,488
• EPS: Not disclosed
• Cash and equivalents: (458)
  • The live webcast and a replay of the webcast will be available on Rocket Lab’s Investor Relations website: https://investors.rocketlabcorp.com/ rocketlabcorp.com | media@rocketlabusa.comMEDIA RELEASERocket Lab Investor Relations Contact Patrick Vorenkampinvestors@rocketlabusa.comRocket Lab Media Contact Murielle Bakermedia@rocketlabusa.comAbout Rocket LabRocket Lab is a leading space company that provides launch services, spacecraft, payloads and satellite components serving commercial, government, and national security markets. Rocket Lab’s Electron rocket is the world’s most frequently launched orbital small rocket; its HASTE rocket provides hypersonic test launch capability for the U.S. government and allied nations; and its Neutron launch vehicle in development will unlock medium launch for constellation deployment, national security and exploration missions. Rocket Lab’s spacecraft and satellite components have enabled more than 1,700 missions spanning commercial, defense and national security missions including GPS, constellations, and exploration missions to the Moon, Mars, and Venus. Rocket Lab is a publicly listed company on the Nasdaq stock exchange (RKLB). Learn more at www.rocketlabcorp.com.Forward Looking StatementsThis press release contains forward
  • looking statements within the meaning of the Private Securities Litigation Reform Act of
  • We intend such forward